Pain and I are well acquainted. I would not go so far as to say we are friends, but we do see each other every day. It isn’t always first thing in the morning; sometimes it’s midafternoon, right after I think to myself, “Wow, pain hasn’t shown up at my…
Bazedoxifene, a medication that alters the activity of the sex hormone estrogen, was safe and well-tolerated but did not promote myelin repair in women with multiple sclerosis (MS) in a Phase 2 clinical trial. The findings come from the ReWRAP study (NCT04002934) and were presented last week at…
A Canadian study is challenging the growing belief that previous infection with the Epstein-Barr virus (EBV) is necessary for multiple sclerosis (MS) to develop. The findings suggest the virus may not precede every MS case. Using public health insurance claims data, the researchers found a small group of…
Better adherence to a Mediterranean-like diet may help prevent disability worsening in people with early multiple sclerosis (MS), in part by slowing biological aging, according to data from a new study. The findings suggest that diet, biological age, and disability are closely connected and that lifestyle changes could…
The investigational BTK inhibitor tolebrutinib did not lower the risk of confirmed disability progression compared with placebo in people with primary progressive multiple sclerosis (PPMS), failing to meet the main goal and several key secondary goals of the Phase 3 PERSEUS trial. It did, however, show signs of…
Get regular updates to your inbox.
